Form 8-A12B KESTRA MEDICAL TECHNOLOG
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF
THE SECURITIES EXCHANGE ACT OF 1934
Kestra Medical Technologies, Ltd.
(Exact name of registrant as specified in its charter)
| Bermuda | Not Applicable | |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
| 3933 Lake Washington Blvd NE, Suite 200 Kirkland, Washington (425) 279-8002 |
98033 | |
| (Address of principal executive offices) | (Zip Code) | |
Securities to be registered pursuant to Section 12(b) of the Act:
| Title of each class to be so registered |
Name of each exchange on which each class is to be registered | |
| Common Shares, par value $1.00 per share | The Nasdaq Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐
Securities Act registration statement or Regulation A offering statement file number to which this form relates:
333-284807
Securities to be registered pursuant to Section 12(g) of the Act:
None
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Registrants Securities to be Registered.
The description of the common shares, par value $1.00 per share, of Kestra Medical Technologies, Ltd. (the Registrant), as set forth under the caption Description of Share Capital in the prospectus forming a part of the Registration Statement on Form S-1 (File No. 333-284807), initially filed by the Registrant with the U.S. Securities and Exchange Commission (the Commission) on February 10, 2025, including exhibits, as subsequently amended (the Registration Statement), is hereby incorporated by reference. In addition, all of the above-referenced descriptions included in any prospectus relating to the Registration Statement filed with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.
Item 2. Exhibits.
Pursuant to the Instructions as to Exhibits section of Form 8-A, no exhibits are required to be filed because no other securities of the Company are registered on the Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
| Date: March 6, 2025 | KESTRA MEDICAL TECHNOLOGIES, LTD. | |||||
| By: | /s/ Brian Webster | |||||
| Name: | Brian Webster | |||||
| Title: | President and Chief Executive Officer | |||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Starts Kestra Medical Technologies (KMTS) at Perform
- Jenny Shin Goes Wire-to-Wire to Capture ISPS HANDA Women's Scottish Open
- After Arrest Controversy, "Empire State Building Couple" Angela Nikolau and Ivan Beerkus to Address Recent Incident on Gosh Live
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share